-
-
Biomarkers for Parkinson's disease and related neurodegenerative diseases occur frequently in patients with idiopathic REM sleep behavior disorder. These include impairment of olfactory and color discrimination, and abnormalities in cerebral blood flow.
-
Entrapment neuropathies are not more common in the setting of chronic inflammatory demyelinating neuropathy and suggest a surgically treatable lesion.
-
Crest failed to demonstrate any significant differ-ence in the primary endpoint (composite of stroke, myocardial infarction, or death during the 4-year follow-up period) between carotid artery stenting (CAS) and carotid endarterectomy (CEA) in patients with symptomatic or asymptomatic carotid artery stenosis.
-
Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
Primary systemic amyloidosis is often complicated by painful, sensory, and autonomic neuropathy.
-
Anti-neuronal antibodies can be detected in Sydenham's chorea, but not in PANDAS or Tourette's syndrome.
-
The King-Devick test, if validated in future studies, has the potential of becoming a standard sideline method for identifying athletes who have sustained a brain injury.
-
Frontal lobe dysfunction may presdispose people to have psychogenic nonepileptic seizures; this dysfunction can be measured by analyzing a brief period of the awake EEG.
-
Chronic fatigue syndrome, as defined by clinical symptoms, may improve with a combination of behavior thrapy and graded exercise.